Results from four rounds of ovarian cancer screening in a randomized trial.


OBJECTIVE To test whether annual screening with transvaginal ultrasonography and CA 125 reduces ovarian cancer mortality. METHODS Data from the first four annual screens, denoted T0-T3, are reported. A CA 125 value at or above 35 units/mL or an abnormality on transvaginal ultrasonography was considered a positive screen. Diagnostic follow-up of positive… (More)
DOI: 10.1097/AOG.0b013e31819cda77


6 Figures and Tables